π Media/Publishing (MED)
Federal lobbying activity for the media/publishing issue area
AI Overview
Media/Publishing (MED) has attracted $203.8M in lobbying spending across 9,746 filings. This issue area sees targeted lobbying from organizations with specific policy interests.
Spending by Year
Top Clients
| # | Client | Spending |
|---|---|---|
| 1 | Coalition of Epscor States | $3.6M |
| 2 | American Clinical Laboratory Association (Acla) | $2.8M |
| 3 | Mass General Brigham | $2.7M |
| 4 | Omeros Corporation | $2.4M |
| 5 | Alliance for Biosecurity | $2.4M |
| 6 | Air Liquide USA LLC | $2.3M |
| 7 | Travere Therapeutics | $2.3M |
| 8 | Public Access to Sunscreens (Pass) Coalition | $2.3M |
| 9 | Loma Linda University Medical Center | $2.1M |
| 10 | Uab Health System | $1.9M |
| 11 | Amgen USA, INC. | $1.8M |
| 12 | Seattle Children's Hospital Research and Foundation | $1.8M |
| 13 | Continuing Medical Education Coalition | $1.7M |
| 14 | Iqvia | $1.7M |
| 15 | Sanofi, U.S. | $1.7M |
| 16 | Children's National Medical Center | $1.6M |
| 17 | Astct | $1.6M |
| 18 | Medisys Health Network | $1.6M |
| 19 | Association for Molecular Pathology | $1.6M |
| 20 | Jazz Pharmaceuticals | $1.6M |
Top Lobbying Firms
| # | Firm | Revenue |
|---|---|---|
| 1 | Cornerstone Government Affairs, INC. | $13.7M |
| 2 | Van Scoyoc Associates | $11.0M |
| 3 | Forbes-tate | $7.1M |
| 4 | The Petrizzo Group, INC. | $6.6M |
| 5 | Brownstein Hyatt Farber Schreck, LLP | $6.3M |
| 6 | Williams and Jensen, PLLC | $6.1M |
| 7 | Squire Patton Boggs | $5.3M |
| 8 | Ballard Partners | $4.9M |
| 9 | Cavarocchi Ruscio Dennis Associates, L.L.C. | $4.8M |
| 10 | Thorn Run Partners | $3.9M |
| 11 | Capitol Counsel LLC | $3.9M |
| 12 | Manatt, Phelps, and Phillips | $3.8M |
| 13 | O'neill, Athy & Casey, P.C. | $3.5M |
| 14 | Ipolicy Solutions | $3.4M |
| 15 | Alston & Bird LLP | $3.3M |
| 16 | Bracewell LLP | $3.2M |
| 17 | Covington & Burling LLP | $3.1M |
| 18 | The Conafay Group, LLC | $2.7M |
| 19 | Powers Pyles Sutter & Verville, P.C. | $2.7M |
| 20 | Impact Health Policy Partners | $2.5M |
Sample Lobbying Descriptions
β’Raising Canndescent's profile in Washington, DC with federal decision makers; intellectual property issues before the US Patent and Trademark Office; promoting Canndescent's research and development o
β’Development of government-private partnerships to advance Alzheimer's therapies.
β’Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition.
β’Issues related to hospital and other provider-related reimbursement, including: graduate medical education, value-based purchasing programs, post acute care, and inclusion of unique device identifiers
β’Medicare payment for hyperbaric oxygen therapy; Use of hyperbaric oxygen therapy for treatment of PTSD and CTE; Research on effectiveness of HBOT for PTSD and CTE for active duty and retired and disab
β’Issues related to payment and delivery reforms, Medicaid benefits and childrens hospital reimbursement. Issues related to pediatric research and childrens hospital graduate medical education.
β’Issues related to FDA diagnostics approval process
β’Veterans administration (structure, benefits, services, and quality of care) Family code (UCCJEA) Federal enforcement of parental rights. Veteran suicide epidemic (root causes, actions, programs, ac
β’FY19 DoD Appropriations; FY19 Labor, HHS, Education Appropriations; FY19 NDAA; Issues related to autism research
β’Federal government relations service, strategy development and implementation relating to companys status of FDA action on NDA for oral testosterone.
Related Analysis
Related Investigations
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.